Benefits of using AI in data management
In part three of this video interview, Diane Lacroix, vice president of clinical data management at eClinical Solutions, touches on some of the biggest benefits realized from the integration of artificial intelligence into data management.
Multinational study finds acupuncture reduces hot flashes caused by breast cancer treatment
Previous research into acupuncture has focused on Western women, but little is known about Asian breast cancer patients.
Goldman Sachs rolls out first generative AI tool across the firm
The company started by centralizing all of its proprietary AI technology onto an in-house platform, an effort that Chief Information Officer Marco Argenti said may have slowed things down at first but is now paying off.
Cell & Gene Therapy CRO Market Trends and Global Forecast, 2035
The “Cell and Gene Therapy CRO Market: Industry Trends and Global Forecast to 2035 – Distribution by Cell Therapy Type, Genetic Modification Type, Development Stage, Therapeutic Area, End User, and Key Geographic Regions” report has been added to ResearchAndMarkets.com’s offering. The global cell and gene therapy CRO market is projected to grow from $1.65 billion in 2024 to $3.51 billion in 2035, exhibiting a CAGR of 7.1% during the forecast period 2024-2035.
Dan Rizzo on LinkedIn
Access to HCPs is difficult. It’s nothing new to anyone who’s worked in the industry for more than a few years. But there’s a lot of variety in how pharmaceutical companies leverage HCP access, which can create a competitive advantage.
A connected engagement model enables commercial organisations to maximise the time they spend with HCPs, strengthening relationships and keeping doors open.
Pharmaceutical Executive, thank you for letting me share my thoughts on this subject.
Have some news you’d like to share on Pharma Pulse? Connect with us on social
Media Editor Miranda Schmalfuss
